Standout Papers

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection 2002 2026 2010 2018 5.0k
  1. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection (2002)
    Michael Fried, Mitchell L. Shiffman et al. New England Journal of Medicine
  2. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C (2004)
    Marianne Ziol, Adriana Handra‐Luca et al. Hepatology

Immediate Impact

16 by Nobel laureates 16 from Science/Nature 96 standout
Sub-graph 1 of 15

Citing Papers

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies
2016 Standout
1 intermediate paper

Works of Daniel Dhumeaux being referenced

Efficacy and Safety of Two-Dose Regimens of Peginterferon Alpha-2a Compared with Interferon Alpha-2a in Chronic Hepatitis C: A Multicenter, Randomized Controlled Trial
2004
What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?
1998
and 1 more

Author Peers

Author Last Decade Papers Cites
Daniel Dhumeaux 13549 11781 2340 272 17.5k
Ulrich Spengler 9171 8144 1695 395 14.6k
Ansgar W. Lohse 12088 10547 4135 474 19.0k
Gregory T. Everson 9911 8380 3698 258 14.1k
Masahiro Kobayashi 11101 9675 1361 469 14.9k
Hiromitsu Kumada 15881 13522 1266 549 19.5k
Antonio Craxı̀ 19193 19269 2448 511 25.6k
Hugo R. Rosen 7762 6676 2073 195 13.5k
Eugene R. Schiff 22320 21998 2608 361 28.2k
Raymond T. Chung 13266 12553 1825 427 22.5k
Peter J. Scheuer 10342 9688 2536 144 14.7k

All Works

Loading papers...

Rankless by CCL
2026